Activity value 77International Buyer&Supplier,Last transaction date:
2026-05-04Address: 16 bazel street p o box 3190 petah tiqva israel fx 03 9267894
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for teva pharmaceutical industrie ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 23 transactions, with a transaction quantity of 25510 and a transaction weight of 130.
YearTransactionsQuantityWeight
2025180588710131
20262325510130
Bill of lading data
<
1/15
>
Trade date
2026/05/04
B/L No.
356414
Suppliers
teva pharmaceutical industrie ltd.
Buyers
тов буст фарма
POLs
——
PODs
київська митниця
Supply area
Israel
Purchas area
Ukraine
Weight
130kg
Amount
138849.86
Hs code
3002150000
Product tags
——
Product description
ІМУНОЛОГІЧНІ ПРОДУКТИ ЯКІ ВИКОРИСТОВУЮТЬСЯ В ЯКОСТІ ЛІКАРСЬКИХ ЗАСОБІВ ДЛЯ ЛЮДЕЙ РОЗФАСОВАНІ ДЛЯ РОЗДРІБНОЇ ТОРГІВЛІ ФІЛГРАСТИМ ВІСТА РОЗЧИН ДЛЯ ІН ЄКЦІЙ АБО ІНФУЗІЙ ПО 48 МЛН МО 0 8 МЛ ПО 0 8 МЛ 48 МЛН МО У ПОПЕРЕДНЬО НАПОВНЕНОМУ ШПРИЦІ ЗПРИСТРОЄМ ДЛЯ БЕЗПЕЧНОГО ВВЕДЕННЯ ПО 5 ПОПЕРЕДНЬО НАПОВНЕНИХ ШПРИЦІВ З ПРИСТРОЄМ ДЛЯ БЕЗПЕЧНОГО ВВЕДЕННЯ У ПАЧЦІ ДІЮЧА РЕЧОВИНА 1 ПОПЕРЕДНЬО НАПОВНЕНИЙ ШПРИЦ 0 8 МЛ РОЗЧИНУ МІСТИТЬ ФІЛГРАСТИМУ 480 МКГ 48 МЛН МО СЕРІЯ 183757 1300 УП КРАЇНАВИРОБНИЦТВА IL ТОРГІВЕЛЬНА МАРКА ФІЛГРАСТИМ ВІСТА ВИРОБНИК ТЕВА ФАРМАЦЕВТІКАЛ ІНДАСТРІЗ ЛТД ВИРОБНИЦТВО ГОТОВОЇ ЛІКАРСЬКОЇ ФОРМИ ПЕРВИННА ТА ВТОРИННА УПАКОВКА КОНТРОЛЬ ЯКОСТІ ВИПУСК СЕРІЇ ІЗРАЇЛЬ ЮАБ ТЕВА БАЛТІКС КОНТРОЛЬ ЯКОСТІ ЛИТВА
Expand
Trade date
2026/02/27
B/L No.
8536338
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETS BEFORE SPAYING OF HOT GELATIN SUBLOT A LOT 2000200691 FOR RESEARCH &100% EOU FOC OPTALGINMETAMIZOLE CAPLETS BEFORE SPAYIN
Expand
Trade date
2026/02/27
B/L No.
4606074
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETS AFTER MILLING SUBLOT B LOT 2000200691 FOR RESEARCH & TESTING PURPOSES100% EOU FOC OPTALGINMETAMIZOLE CAPLETS AFTER MILLING
Expand
Trade date
2026/02/27
B/L No.
2118680
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETS AFTER 20MIN OF DRYING SUBLOT A LOT 2000200691 FOR RESEARCH & TESTING P100% EOU FOC OPTALGINMETAMIZOLE CAPLETS AFTER 20MIN OF
Expand
Trade date
2026/02/27
B/L No.
1241677
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETSAFTER 20MIN OF DRYING SUBLOT B LOT 2000200691 FOR RESEARCH & TESTING PU100% EOU FOC OPTALGINMETAMIZOLE CAPLETSAFTER 20MIN OF
Expand
Trade date
2026/02/27
B/L No.
3328536
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETS STARTING OF DRYING SUBLOT A LOT 2000200691 FOR RESEARCH & TESTING PURP100% EOU FOC OPTALGINMETAMIZOLE CAPLETS STARTING OF DR
Expand
Trade date
2026/02/27
B/L No.
3673487
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC METAMIZOLE API LOT 5000042918 FOR RESEARCH & TESTING PURPOSES ONLY 100% EOU FOC METAMIZOLE API LOT 5000042918 FOR RESEA
Expand
Trade date
2026/02/27
B/L No.
2706140
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETSAFTER 10MIN OF DRYING SUBLOT B LOT 2000200691 FOR RESEARCH & TESTING P100% EOU FOC OPTALGINMETAMIZOLE CAPLETSAFTER 10MIN OF
Expand
Trade date
2026/02/27
B/L No.
7453334
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETS END OF DRYING SUBLOT A LOT 2000200691 FOR RESEARCH & TESTING PURPOSES100% EOU FOC OPTALGINMETAMIZOLE CAPLETS END OF DRYING
Expand
Trade date
2026/02/27
B/L No.
4882706
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETSAFTER 10MIN OF DRYING SUBLOT A LOT 2000200691 FOR RESEARCH & TESTING P100% EOU FOC OPTALGINMETAMIZOLE CAPLETSAFTER 10MIN OF
Expand
Trade date
2026/02/27
B/L No.
0644723
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETSEND OF DRYING SUBLOT B LOT 2000200691 FOR RESEARCH & TESTING PURPOSES100% EOU FOC OPTALGINMETAMIZOLE CAPLETSEND OF DRYING
Expand
Trade date
2026/02/27
B/L No.
4178768
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETSSTARTING OF DRYING SUBLOT B LOT 2000200691 FOR RESEARCH & TESTING PURP100% EOU FOC OPTALGINMETAMIZOLE CAPLETSSTARTING OF DR
Expand
Trade date
2026/02/27
B/L No.
2175456
Suppliers
teva pharmaceutical industrie ltd.
Buyers
actavis pharma development centre
Product description
100% EOU FOC OPTALGINMETAMIZOLE CAPLETS AFTER FINAL MIXING LOT 2000200691 FOR RESEARCH & TESTING PURPOSES ONL100% EOU FOC OPTALGINMETAMIZOLE CAPLETS AFTER FINAL M
Expand
5тов тева україна
ukrainebuyer,they trade on 2021-02-11
540.97%
>
+View All
Products
Total 271
ProductsTransactionsPerDetail
bat 41977.16%>
sear 37068.14%>
ting 34964.27%>
tablet 19836.46%>
carton 12623.2%>
+View All
Hscode rank
Total 125
HSCode NameTransactionsPerDetail
HS 3004909937969.8%>
HS 300490000291.66%>
HS 3004900050.92%>
HS 382219000940.74%>
HS 300212000230.55%>
+View All
Trading Area
Total 12
AreaTransactionsPerDetail
india133223.95%>
united states103618.63%>
russia1662.99%>
kazakhstan611.10%>
ukraine591.06%>
+View All
Port statistics
Total 5
Port NameTransactionsPerDetail
haifa99517.89%>
ashdod270.49%>
київ60.11%>
amsterdam10.02%>
ua велика олександрівка10.02%>
teva pharmaceutical industrie ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,sear,ting.
According to the 52wmb.com global trade database, as of 2026-05-04, the company has completed 5561 international trades,
with its main trading regions covering india,united states,russia etc.
The core products include HS30049099,HS3004900002,HS30049000 etc,
often transported via haifa,port ashdod, port київ etc,
and its main trading partners are actavis pharma development centre,teva usa pharmaceuticals usa inc.,ооо тева.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on teva pharmaceutical industrie ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.